Schedule 13G ownership disclosure

TIANYIN PHARMACEUTICAL CO., INC.

Security class unavailable · CUSIP: 88630M104

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
745,175
Percent of class
2.5300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001166134-16-000016
Form type
SC 13G
Filer
POPE ASSET MANAGEMENT, LLC
CIK
CIK 1166134
Filed
Feb 17, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub